Search

Your search keyword '"Euronext Paris S.A. -- Licensing agreements"' showing total 5 results
Start Over Descriptor "Euronext Paris S.A. -- Licensing agreements" Topic pharmaceutical industry -- licensing agreements
5 results on '"Euronext Paris S.A. -- Licensing agreements"'

1. Sanofi and Novavax sign co-exclusive licensing agreement

Subjects
Novavax Inc. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Biotechnology industry -- Licensing agreements, Influenza vaccines -- Licensing agreements, Health care industry -- Licensing agreements, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-May 10, 2024-Sanofi and Novavax sign co-exclusive licensing agreement (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Novavax Inc (Nasdaq:NVAX) announced [...]

Published
2024

2. Sanofi and Novavax sign co-exclusive licensing agreement

Subjects
Novavax Inc. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Biotechnology industry -- Licensing agreements, Influenza vaccines -- Licensing agreements, Health care industry -- Licensing agreements, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-May 10, 2024-Sanofi and Novavax sign co-exclusive licensing agreement (C)2024 M2 COMMUNICATIONS French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Novavax Inc (Nasdaq:NVAX) announced on [...]

Published
2024

3. Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers

Subjects
Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Killer cells, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Securities industry, Company licensing agreement, General interest, News, opinion and commentary
Abstract

MARSEILLE: INNATE PHARMA SA has issued the following news release: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') announced today the expiration of the waiting period [...]

Published
2023

4. Takeda Licenses Innate Pharma Antibodies for Celiac Disease Research Program

Subjects
Euronext Paris S.A. -- Licensing agreements, Celiac disease, Medical research, Medicine, Experimental, Biological products -- Licensing agreements, Viral antibodies, Antibodies, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Securities industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-April 4, 2023-Takeda Licenses Innate Pharma Antibodies for Celiac Disease Research Program (C)2023 M2 COMMUNICATIONS - France-based biotechnology company Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) has entered [...]

Published
2023

5. Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers

Subjects
Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Health care industry -- Licensing agreements, Killer cells, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-January 25, 2023-Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Innate Pharma SA (Euronext Paris: IPH) (Nasdaq: IPHA), [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results